Drug Shortage Report for HAVRIX 1440

Last updated on 2024-02-22 History
Report ID 209700
Drug Identification Number 02187078
Brand name HAVRIX - SUS IM 1440 ELISA UNITS/ML
Common or Proper name hepatitis A vaccine, inactivated
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED
Strength(s) 1440UNIT
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1's (prefilled syringe / seringue préremplie)
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-11-06
Estimated end date 2024-02-26
Actual end date 2024-02-21
Shortage status Resolved
Updated date 2024-02-22
Company comments Supply available for public programs. Supply unavailable in the private market.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-02-22 English Compare
v9 2024-02-21 French Compare
v8 2024-02-21 English Compare
v7 2024-02-16 French Compare
v6 2024-02-16 English Compare
v5 2024-01-10 French Compare
v4 2024-01-10 English Compare
v3 2023-11-10 French Compare
v2 2023-11-10 English Compare
v1 2023-11-10 English Compare

Showing 1 to 10 of 10